Finzati - Logo
IRWD logo

Ironwood Pharmaceuticals, Inc.

IRWD • Drug Manufacturers - Specialty & Generic
$4.26
▼ -0.03 (-0.70%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$701.25M
Growth
7.8%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 8.1%Positive free cash flow · 0.78Consistent free cash flow · 5/5Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:22 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.26
Change-0.70%
Market Cap$701.25M
52W Range0.81 - 5.78
Beta0.21
Gross Margin100.00%
Oper. Margin40.10%
Profit Margin8.11%
Debt/Eq-2.28
Current Ratio1.13
Quick Ratio1.13
Revenue 5Y7.76%

Investment DNA

How strong this company looks for long-term investors

62
out of 100
Business Quality
Margins, moat, returns
64/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
81/100
Why this score▼
Stable or improving margins · 8.1%Positive free cash flow · 0.78Consistent free cash flow · 5/5Negative growth trend

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$3.70
Mean
$3.70
Median
$3.70
High
$3.70

Company Overview

IPO: 2/3/2010
Industry: Drug Manufacturers - Specialty & Generic
P/B i: -2.09
Debt / Equity i: -2.28
Operating Margin: 40.10%
Net Margin: 8.11%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: -2.28
Current Ratio: 1.13
Quick Ratio: 1.13
Status: Moderate

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Silber Jeffrey
Transaction: 07/20/2026
OTHER
Change
0
Price
Not reported
Filing
07/22/2026
Type
OTHER
Silber Jeffrey
Transaction: 07/20/2026
BUY
Change
+137,036
Price
Not reported
Filing
07/22/2026
Type
BUY
Silver Ronald
Transaction: 07/07/2026
SELL
Change
-127,890
Price
$4.52
Filing
07/09/2026
Type
SELL